We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Montanaro European Smaller C. Tst Plc | LSE:MTE | London | Ordinary Share | GB00BM8H3X05 | ORD 5P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
134.50 | 135.50 | 135.50 | 134.00 | 134.00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | -18.94M | -23.18M | -0.1224 | -10.99 | 254.78M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:35:27 | UT | 1,050 | 134.50 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
18/4/2024 | 12:30 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
17/4/2024 | 11:33 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
16/4/2024 | 12:44 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
15/4/2024 | 13:01 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
12/4/2024 | 11:16 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
11/4/2024 | 11:10 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
10/4/2024 | 11:27 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
09/4/2024 | 11:04 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
08/4/2024 | 11:44 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
05/4/2024 | 11:51 | UK RNS | Montanaro European Smaller C.TstPLC Net Asset Value(s) |
Montanaro European Small... (MTE) Share Charts1 Year Montanaro European Small... Chart |
|
1 Month Montanaro European Small... Chart |
Intraday Montanaro European Small... Chart |
Date | Time | Title | Posts |
---|---|---|---|
02/11/2023 | 08:05 | Montanaro European Smaller Companies | 33 |
16/6/2011 | 19:34 | MTE - Metrocoal | 1 |
24/2/2004 | 18:59 | MITIE - a mighty profit to be had by Monday | 3 |
28/8/2002 | 10:44 | Cannot believe no-one has noticed this | 7 |
07/3/2002 | 12:22 | does anybody have any information about mission testing.plc? | 25 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2024-04-18 15:35:27 | 134.50 | 1,050 | 1,412.25 | UT |
2024-04-18 15:26:43 | 134.50 | 5,644 | 7,591.18 | AT |
2024-04-18 15:26:33 | 134.50 | 317 | 426.37 | AT |
2024-04-18 15:26:33 | 134.50 | 690 | 928.05 | AT |
2024-04-18 15:26:33 | 134.50 | 1,416 | 1,904.52 | AT |
Top Posts |
---|
Posted at 18/4/2024 09:20 by Montanaro European Small... Daily Update Montanaro European Smaller C. Tst Plc is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker MTE. The last closing price for Montanaro European Small... was 135p.Montanaro European Small... currently has 189,427,600 shares in issue. The market capitalisation of Montanaro European Small... is £254,780,122. Montanaro European Small... has a price to earnings ratio (PE ratio) of -10.99. This morning MTE shares opened at 134p |
Posted at 17/11/2021 09:10 by dr biotech Me too. Have more of these than any individual share, although my UK smaller companies holdings are somewhat larger. Quite like trusts as for me they are just buy and hold and I don’t think about what to trade. |
Posted at 03/9/2021 20:42 by yogi Busy thread in last 24 hrs! Noticed the reduced price yesterday but ignored as the offer price was in line with earlier trading and Share pad which I use also takes closing offer prices. Creeping up nicely here over recent times - I also hold BRSC which is the UK equivalent and has a similarly nice trend line- good weekend to all.. |
Posted at 03/9/2021 15:18 by smithers Thank you for doing the work and for sharing the very good explanation from Montanaro regarding the price anomaly.I continue to hold MTE and will probably add |
Posted at 03/9/2021 13:27 by lozzer69 I emailed Montanaro and got this explanation by return which was impressive. ......I have spoken with Cenkos, brokers for MTE, who have stated there was an anomaly of a poorly executed trade, not representative of the underlying ongoing price development. The company has been especially successful over the last year in particular of having a much closer price and NAV correlation than its history, but also versus its peers.The anomaly was due to an 'unlimited' sell order placed in the closing auction, of around 2000 shares. Whoever placed the order should normally have put a limit on this, to avoid this outcome. At 16.30 - 16.35 there is an auction and if there is insufficient demand at the market level at that time, then the trade, when placed this way, can force an unnatural 'crossing price'. Unhelpfully the closing auction is taken as the closing price, but is in no way representative of the price during the day, week or indeed today. Hence the price was instantly corrected at 08.00 this morning. |
Posted at 03/9/2021 10:08 by smithers Probably ADVFN using last trade of the day price which was a UT trade at 2030p |
Posted at 16/6/2011 19:34 by schweinswal Metrocoal -- by RBS Morgans LtdBillion tonne baby :-) Target $1 AUD |
Posted at 11/3/2002 17:52 by stewjames Still keen on MTE BTW, just feel the market will hit the 'bad' news at the full year (even though it's expected) and it'll move sideways at best in the meantime. Just a question of timing. But I've been wrong plenty of times before! |
Posted at 06/3/2002 20:17 by captainspock Huge mark-up on low volume !!!I reckon if we see some large trades by Friday, £2.00+ cannot be far away despite the cautious outlook on FY profits. After all the float price was only around £2.80 |
Posted at 06/3/2002 13:10 by mike_c I would guestimate this share has been totally oversold upto this point... hence its markup after every buy. |
Posted at 07/11/2001 16:03 by castana Financial ReviewMission Testing, in its first year as a public company, has met all of the financial aims that it set for itself at the time of its admission to AIM. The Group has achieved an excellent set of results for the year, with future financial indicators looking strong and the completion of our first acquisition in August 2001. Results Mission Testing continued its rapid organic growth in the current year, building on the trend of previous periods as shown below. Year to 2001 £’000 Year to 2000 £’000 15 months to 1999 £'000 Turnover 10,515 6,048 2,220 Gross profit GP% 2,713 25.8% 1,350 22.3% 434 19.5% Administrative expenses (1,609) (747) (228) Operating profit before interest and tax (pre-exceptionals) 1,104 603 206 Operating margin (pre-exceptionals) 10.5% 10% 9.3% PBT (pre-exceptionals) 1,277 500 162 PBT margin (pre-exceptionals) 12.1% 8.3% 7.3% Exceptional float related costs (310) - - Profit after tax 630 371 128 Turnover increased organically by 74% to £10.5m reflecting strong demand for our services, despite a general tightening of markets. The entire turnover is generated from the supply of testing services. Gross profit increased by 101% to £2.7m. The underlying increase in gross profit percentage of 3.5% to 25.8% is in line with our strategy and this is a trend that we would expect to continue as Group turnover increases by the growing contribution from high-margin consultancy services. Administrative expenses have been well controlled and have increased in line with our investment in the sales, fee earning and support people required to grow the business still further. The Group has increased its investment in sales and fee earning employees, focusing on the delivery of services across focused market sectors. Operating profit (pre-exceptionals) increased by 83% to £1.1m from £0.6m, while the operating margin (pre-exceptionals) grew from 10% in 2000 to 10.5% in 2001. The PBT margin (pre-exceptionals) grew from 8.3% in 2000 to 12.1% in 2001. The exceptional costs of £310,000 relate to the flotation of the Group on the Alternative Investment Market of the London Stock Exchange on 6 December 2000, that have not been written off against the share premium account. Fee earners It is the Group’s strategy to utilise contractors where appropriate, due to management of fixed overhead risk that comes from this structure; contractors, often referred to as “associates Interest Interest income was £258,000 (2000: £1,000). This increase is due to interest earned on the funds received from the placing that took place with the flotation in December 2000. The funds, net of float costs, of £8.8m have been on deposit with our principal bankers. Taxation The taxation charge of £337,000 represents an effective tax rate of 34.8% compared to 25.8% for the previous year. This is mainly due to disallowable float related expenses. Earnings per share Basic earnings per share (pre-exceptionals) increased by 94% from 3.31p in 2000 to 6.41p in 2001, while fully diluted earnings per share (pre-exceptionals), increased by 88% from 3.31p in 2000 to 6.22p in 2001. Dividend and shareholder returns The Directors propose a final dividend of 1.5p per share, which is the first dividend payable to shareholders since the company’s admission to AIM in December 2000. This dividend is covered 4.3 times by adjusted basic earnings per share. Balance Sheet The balance sheet was strengthened by the float proceeds of £8.8m, net of float costs. Cash at 30 June 2001 was £9m with no borrowings. Shareholders funds at 30 June 2001 were £9.7m (2000: £0.3m). Whilst we have, as required by the steep organic growth during year, used a modest amount of cash to finance working capital needs, the balance of these funds is available for our acquisition plans. £700,000 was utilised in the acquisition of Specialist Testing Solutions Ltd in August. Acquisitions On 24 August 2001 the Group acquired the entire issued share capital of Specialist Testing Solutions Ltd for an aggregate consideration of £3.7 million which was satisfied by £700,000 of cash on completion and 1,600,000 new ordinary shares in Mission Testing plc. Of these shares 1,350,000 were issued on completion and a further 250,000 will be issued following Mission Testing’s AGM to be held on 7 November 2001. Summary The Group is in a very healthy financial position. The strong organic growth together with the acquisition of Specialist Testing Solutions ensures that the Group is well placed to enjoy future growth prospects. David Abery Finance Director 17 September 2001 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions